Search

everythinglearnresearchcommunity

for

Search:↓

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

The committee decided not to approve the drug due to low effectiveness and high risks.

Bimatoprost is safe and effective for improving eyebrow hair.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

New psoriasis treatments are effective but come with side effects and risks.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Monitoring for adverse effects in clinical treatments is crucial.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Finasteride use during early pregnancy may cause limb deformities in babies.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Mesotherapy for hair loss lacks evidence of effectiveness and safety and should not be used without further scientific support.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

There are many treatments for common hair loss, but more trials are needed to decide which are best.